Handelsavisen
prelaunch
Companies Healthcare 6808.TWO
68
6808.TWO TPEx Medical Equipment, Supplies & Distribution

6808.Two

$30,90
Open in Charts → Attach watcher ⌖
TWD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
2,4B TWD
P/E
EV / Rev
Div yield
1,55 %
Op margin
20,4 %
ROE
6,8 %
Net margin
32,2 %
Debt / equity
0,05
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

6808.TWO is a medical equipment and supplies company that generates revenue primarily through the distribution and sale of healthcare products and services.

Business. 6808.TWO is a medical equipment and supplies company that generates revenue primarily through the distribution and sale of healthcare products and services.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
ActivityHealthcare Services & Equipment
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
6,8 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 6808.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 6808.TWO. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    6808.TWO is a medical equipment and supplies company that generates revenue primarily through the distribution and sale of healthcare products and services.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryMedical Equipment, Supplies & Distribution
    ActivityHealthcare Services & Equipment
    AI synthesis
    GENERATED

    6808.TWO has a strong liquidity position, as evidenced by a current ratio of 14.08, indicating that the company holds significantly more current assets than current liabilities. The company's liquidity is further supported by a low debt-to-equity ratio of 0.05, suggesting that it is not heavily leveraged and has a strong equity base. However, the company's net cash position is negative after subtracting total debt, which could indicate potential liquidity constraints in the short term.

    In terms of profitability, 6808.TWO reports a return on equity (ROE) of 6.76% and a return on assets (ROA) of 6.1%, which are key metrics for evaluating the efficiency of capital use and asset management. These figures suggest that the company is generating a moderate return on its equity and assets, but the performance relative to industry medians is not explicitly provided in the data. The company's gross profit margin is 71.8%, and its operating margin is 20.35%, indicating a healthy margin structure.

    The company's revenue is concentrated in a single business segment, as no specific segments are disclosed in the financial data. Geographically, the data does not provide a breakdown of revenue by region, so it is unclear whether the company has significant exposure to any particular geographic market. This lack of segmentation detail limits the ability to assess the company's diversification and potential exposure to regional economic or regulatory risks.

    Looking at the growth trajectory, the data does not provide specific revenue growth figures for the current or next fiscal year. However, the company's operating cash flow of 110,905,000 TWD and free cash flow of 46,605,000 TWD suggest that it has the capacity to fund operations and potentially invest in growth initiatives. The capital expenditure of -6,306,000 TWD indicates that the company is not currently investing heavily in new capital assets, which may suggest a focus on maintaining existing operations rather than expanding.

    The risk assessment for 6808.TWO identifies liquidity as a medium risk and dilution as a low risk. The company's liquidity risk is partially offset by its strong current ratio, but the negative net cash position after debt is a concern. The dilution risk is low, and there is no indication of significant dilution potential in the near term. The company's financial structure and cash flow generation capabilities suggest that it is in a relatively stable position, but the negative net cash position could pose a challenge if not managed effectively.

    Recent events and filings for 6808.TWO are not detailed in the provided data, so it is not possible to assess the impact of any recent developments on the company's financial position or strategic direction. The absence of specific information on recent events means that the company's response to market changes or regulatory developments cannot be evaluated based on the available data.

    Key takeaways
    • 6808.TWO has a strong liquidity position with a current ratio of 14.08 and a low debt-to-equity ratio of 0.05.
    • The company's profitability is moderate, with a return on equity of 6.76% and a return on assets of 6.1%.
    • The company's revenue is concentrated in a single business segment, and there is no geographic revenue breakdown provided.
    • The company's operating cash flow and free cash flow suggest it has the capacity to fund operations and potentially invest in growth.
    • The risk assessment identifies liquidity as a medium risk and dilution as a low risk, with a negative net cash position after debt being a concern.
    • Recent events and filings for 6808.TWO are not detailed in the provided data, limiting the ability to assess the impact of recent developments.

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $30,90
    Market cap
    $2.34B
    Enterprise value
    $2.39B
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    21.5x
    P / B
    2.4x
    P / Tangible book
    2.4x
    Tangible book
    $984.5M
    Net cash
    -$48.7M
    Current ratio
    14.1
    Debt / equity
    0.1
    ROA
    6.1%
    ROE
    6.8%
    Cash conversion
    167.0%
    CapEx / revenue
    -3.0%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin20,3 %Above P75
    Net Margin32,2 %Best in class
    ROE6,8 %Above median
    Capex / Rev-3,0 %Above median
    D/E0,05Above median
    Cash Conv1,67Above P75

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Ev To Operating Cash Flow
      enterprise_value / operating_cash_flow
    • Return On Equity
      net_income / total_equity
    • Price To Earnings
      market_price / (net_income / shares_outstanding_diluted)
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    Source documents
    • 6808.TWO Market data — financials · 2026-05-27

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    6808.TWOCanonical
    TPEx · TWD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage